Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 616 AL 630

Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease

de Bruin H, Groot C, Barthel H, Bischof GN, Blazhenets G, Boellaard R, Boon BDC, Brendel M, Cash DM, Coath W, Day GS, Dickerson BC, Doering E, Drzezga A, van Dyck CH, van Eimeren T, van der Flier WM, Fredericks CA, Fryer TD, van de Giessen E, Gordon BA, Graff-Radford J, Grinberg LT, Hansson O, Hobbs DA, Hoenig MC, Höglinger G, Irwin DJ, Jones PS, Josephs KA, Katsumi Y, La Joie R, Lee EB, Levin J, Malpetti M, McGinnis SM, Mecca AP, Mohanty R, Nasrallah IM, O'Brien JT, O'Dell RS, Palleis C, Perneczky R, Phillips JS, Putcha D, Rabinovici GD, Rahmouni N, Rosa-Neto P, Rowe JB, Rullmann M, Sabri O, Saur D, Schildan A, Schott JM, Schroeter ML, Seeley WW, Servaes S, Sintini I, Smith R, Spina S, Stevenson J, Stomrud E, Strandberg O, Therriault J, Tideman P, Touroutoglou A, Trainer AE, Visser D, Wekselman F, Weston PSJ, Whitwell JL, Wolk DA, Yong K, Pijnenburg YAL, Franzmeier N, Ossenkoppele R.

Brain. 2025 Nov 4;148(11):3893-3912. doi: 10.1093/brain/awaf279.

Immunogenicity of a recombinant subunit COVID-19 vaccine: A prospective, multi-centre, longitudinal study in Chinese Alzheimer's disease patients

Weng Y, Huang Y, Zhang J, Wu Y, He Q, Litchev S, Wu A, Ling Z, Zhao L, Liao R, Shao L, Wang M, Xu Y, Gong R, Zhang Z, Wang Y, Wu TT, Lu S, Kong Q, Lv H.

Hum Vaccin Immunother. 2025 Dec;21(1):2591504. doi: 10.1080/21645515.2025.2591504. Epub 2025 Dec 3.

Assessing brain vascular impairment, white matter lesions and ApoE status as predictors of behavioral and psychological symptoms of dementia (BPSD) in a multicentre sample of patients with Alzheimer's disease: a multidisciplinary retrospective study

Vaianella L, Bove R, Giuliani A, Pavino V, Guglielmi V, Giacomini G, Rossi C, Massimetti MC, Iani C, Bizzarro A.

Ann Ist Super Sanita. 2025 Jan-Mar;61(1):42-49. doi: 10.4415/ANN_25_01_06.

A Preliminary Study on an Intelligent Segmentation and Classification Model for Amygdala-Hippocampus MRI Images in Alzheimer's Disease

Liu S, Zhou K, Geng D.

Acad Radiol. 2025 Dec;32(12):7459-7470. doi: 10.1016/j.acra.2025.08.039. Epub 2025 Sep 2.

Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study

Guo R, Li D, Li F, Ji L, Liu H, Qiao H, Lv Z, Tang Y, Wang D.

J Alzheimers Dis. 2025 Mar;104(1):52-60. doi: 10.1177/13872877251313819. Epub 2025 Feb 5.

Meta-Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross-Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross-Study Heterogeneity

Hou J, Hess JL, Zhang C, van Rooij JGJ, Hearn GC, Fan CC, Faraone SV, Fennema-Notestine C, Lin SJ, Escott-Price V, Seshadri S; Alzheimer's Disease Neuroimaging Initiative; Holmans P, Tsuang MT, Kremen WS, Gaiteri C, Glatt SJ.

Am J Med Genet B Neuropsychiatr Genet. 2025 Jun;198(4):e33019. doi: 10.1002/ajmg.b.33019. Epub 2024 Dec 16.

Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023

Anschuetz A, Schwab K, Harrington CR, Wischik CM, Riedel G.

J Alzheimers Dis. 2025 Sep;107(2):452-476. doi: 10.1177/13872877251362212. Epub 2025 Sep 1.

VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis

Ye H, Zhuang C, Jin Z, Hu Y, He J, Yu Q, Hu H, Zheng Y.

J Alzheimers Dis. 2025 Dec;108(3):1073-1087. doi: 10.1177/13872877251385244. Epub 2025 Oct 17.

Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO

Puerta R, de Rojas I, García-González P, Olivé C, Sotolongo-Grau O, García-Sánchez A, García-Gutiérrez F, Montrreal L, Tartari JP, Sanabria Á, Pytel V, Lage C, Quintela I, Aguilera N, Rodriguez-Rodriguez E, Alarcón-Martín E, Orellana A, Pastor P, Pérez-Tur J, Piñol-Ripoll G, López de Munain A, García-Alberca JM, Royo JL, Bullido MJ, Álvarez V, Real LM, Corbatón Anchuelo A, Gómez-Garre D, Martínez Larrad MT, Franco-Macías E, Mir P, Medina M, Sánchez-Valle R, Dols-Icardo O, Sáez ME, Carracedo Á, Tárraga L, Alegret M, Valero S, Marquié M, Boada M, Sánchez Juan P, Cavazos JE, Cabrera-Socorro A, Cano A, Ruiz A; Alzheimer’s Disease Neuroimaging Initiative.

Funct Integr Genomics. 2025 Mar 25;25(1):73. doi: 10.1007/s10142-025-01581-6.

Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition

Kim JP, Jung SH, Jang B, Cho M, Song M, Kim J, Kim B, Lee H, Shin D, Lee EH, Jang H, Kim BH, Ham H, Kim D, Raj T, Cruchaga C, Kim HJ, Na DL, Seo SW, Won HH.

Nat Commun. 2025 Apr 2;16(1):3150. doi: 10.1038/s41467-025-57751-4.

The whole-brain structural and functional connectome in Alzheimer's disease spectrum: A multimodal Bayesian meta-analysis of graph theoretical characteristics

Liu W, Zuo C, Chen L, Lan H, Luo C, Li X, Kemp GJ, Lui S, Suo X, Gong Q.

Neurosci Biobehav Rev. 2025 Jul;174:106174. doi: 10.1016/j.neubiorev.2025.106174. Epub 2025 Apr 24.

The Footprint of CHASERR as a Potential Culprit in Alzheimer's Disease Patients: An In-Silico-Experimental Study

Khosroabadi Z, Niazmand A, Mousavi SR, Hosseini N, Bagheri N, Chitsaz A, Salehi M.

Curr Alzheimer Res. 2025;22(3):205-218. doi: 10.2174/0115672050381537250422075255.

Identification of 16 novel Alzheimer's disease loci using multi-ancestry meta-analyses

Willett JDS, Waqas M, Choi Y, Ngai T, Mullin K, Tanzi RE, Prokopenko D.

Alzheimers Dement. 2025 Feb;21(2):e14592. doi: 10.1002/alz.14592.

Gut microbiota dysbiosis in Alzheimer's disease (AD): Insights from human clinical studies and the mouse AD models

Manfredi JN, Gupta SK, Vyavahare S, Deak F, Lu X, Buddha L, Wankhade U, Lohakare J, Isales C, Fulzele S.

Physiol Behav. 2025 Mar 1;290:114778. doi: 10.1016/j.physbeh.2024.114778. Epub 2024 Dec 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias